About us.
Find out how we’re transforming ideas into impact at scale through the businesses we identify, back and grow.
Our portfolio.
Investors.
We have a proven track-record in backing and nurturing science and technology-based businesses to deliver a better future for people and planet.
Our impact.
Find out how we’re living our purpose and identifying, backing and growing businesses that contribute to a healthier, tech-enriched, sustainable future.
News & Events.
Open and close mobile menu
IP Group news
13 Oct 2025
Update on potential future royalty income from Metsera obesity drug candidates
IP Group plc
08 Oct 2025
Portfolio company Monolith to be acquired by CoreWeave
29 Sep 2025
Portfolio company OXCCU raises £20.75m in Series B funding to scale sustainable aviation fuel from waste carbon
Portfolio news
16 Oct 2025
Genomics launches Mystra: the world’s first and original AI-enabled human genetics platform, now available to transform drug target discovery and clinical development
Genomics
15 Oct 2025
Mission Therapeutics raises $13.3 million to progress first-in-class Parkinson’s disease candidate MTX325 through clinical trials
Mission Therapeutics Limited
14 Oct 2025
Akamis Bio Receives FDA Fast Track Designation for NG-350A for the Treatment of Mismatch Repair-Proficient Locally Advanced Rectal Cancer
Akamis Bio
08 Aug 2025
16 Jul 2025
17
Virtual
Event has passed
26
45 Gresham Street, London
12
Hybrid
